nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk
|
Sydnor, Valerie J. |
|
|
226 |
C |
p. 61-69 |
artikel |
2 |
An imaging-based risk calculator for prediction of conversion to psychosis in clinical high-risk individuals using glutamate 1H MRS
|
Kegeles, Lawrence S. |
|
|
226 |
C |
p. 70-73 |
artikel |
3 |
Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?
|
Cao, Ting |
|
|
226 |
C |
p. 95-110 |
artikel |
4 |
Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes
|
Cui, Huiru |
|
|
226 |
C |
p. 138-146 |
artikel |
5 |
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people
|
Alqarni, Ayedh |
|
|
226 |
C |
p. 44-51 |
artikel |
6 |
Editorial Board
|
|
|
|
226 |
C |
p. IFC |
artikel |
7 |
Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms
|
Millman, Zachary B. |
|
|
226 |
C |
p. 111-119 |
artikel |
8 |
Grey-matter abnormalities in clinical high-risk participants for psychosis
|
Zikidi, Katia |
|
|
226 |
C |
p. 120-128 |
artikel |
9 |
Guest Editorial: Special issue on “Biomarkers in the attenuated psychosis syndrome”
|
Cadenhead, Kristin S. |
|
|
226 |
C |
p. 1-4 |
artikel |
10 |
Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness
|
Kelsven, Skylar |
|
|
226 |
C |
p. 13-23 |
artikel |
11 |
Language as a biomarker for psychosis: A natural language processing approach
|
Corcoran, Cheryl M. |
|
|
226 |
C |
p. 158-166 |
artikel |
12 |
Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis
|
Park, Sora |
|
|
226 |
C |
p. 5-12 |
artikel |
13 |
Modeling perception and behavior in individuals at clinical high risk for psychosis: Support for the predictive processing framework
|
Kafadar, Eren |
|
|
226 |
C |
p. 167-175 |
artikel |
14 |
P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature
|
Tang, Yingying |
|
|
226 |
C |
p. 74-83 |
artikel |
15 |
Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium
|
Cao, Hengyi |
|
|
226 |
C |
p. 30-37 |
artikel |
16 |
Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study
|
Oliver, Dominic |
|
|
226 |
C |
p. 176-183 |
artikel |
17 |
Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study
|
Berger, Maximus |
|
|
226 |
C |
p. 38-43 |
artikel |
18 |
Relationships between cognitive event-related brain potential measures in patients at clinical high risk for psychosis
|
Lepock, Jennifer R. |
|
|
226 |
C |
p. 84-94 |
artikel |
19 |
Reprint of: Internalising symptoms mediate the longitudinal association between childhood inflammation and psychotic-like experiences in adulthood
|
Francesconi, Marta |
|
|
226 |
C |
p. 24-29 |
artikel |
20 |
Social reward processing: A biomarker for predicting psychosis risk?
|
Pelletier-Baldelli, Andrea |
|
|
226 |
C |
p. 129-137 |
artikel |
21 |
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis
|
Alqarni, Ayedh |
|
|
226 |
C |
p. 52-60 |
artikel |
22 |
Thalamus-related anomalies as candidate mechanism-based biomarkers for psychosis
|
Steullet, Pascal |
|
|
226 |
C |
p. 147-157 |
artikel |